Increased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNFα

Nature Communications

Volumn 6, Issue , 2015, Pages

  Aschar Sobbi, Roozbeh ^a   Izaddoustdar, Farzad ^a   Korogyi, Adam S ^a   Wang, Qiongling ^b   Farman, Gerrie P ^c   Yang, Fenghua ^a   Yang, Wallace ^a   Dorian, David ^a   Simpson, Jeremy A ^d   Tuomi, Jari M ^e,j   Jones, Douglas L ^e   Nanthakumar, Kumaraswamy ^a,f   Cox, Brian ^a,g   Wehrens, Xander H T ^b   Dorian, Paul ^a,h   Backx, Peter H ^a,f,i  

^a UNIVERSITY OF TORONTO   (Canada)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c BOSTON UNIVERSITY   (United States)

^d UNIVERSITY OF GUELPH   (Canada)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^h ST MICHAEL'S HOSPITAL   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DOBUTAMINE; ETANERCEPT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROPRANOLOL; RYANODINE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ARRAY; INHIBITION; NUMERICAL MODEL; PATHOLOGY; RODENT; VULNERABILITY;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDURANCE TRAINING; ENZYME INHIBITION; FIBROSIS; HEART ATRIUM ARRHYTHMIA; HEART CONDUCTION; HEART FUNCTION; HEART MUSCLE CELL; HEART RATE; HEART VENTRICLE CONTRACTILITY; HYPERTROPHY; INFLAMMATION; MALE; MOUSE; NEWBORN; NONHUMAN; PARASYMPATHETIC NERVE; PATHOPHYSIOLOGY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SWIMMING; TREADMILL EXERCISE; VAGUS TONE; VELOCITY; ANIMAL; ATRIAL FIBRILLATION; EXERCISE; HEART ATRIUM; METABOLISM; PHYSIOLOGY;

MUS;

ANIMALS; ATRIAL FIBRILLATION; HEART ATRIA; HEART RATE; MALE; MICE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHYSICAL EXERTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84923073606     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7018     Document Type: Article

References (70)

1. Nattel, S. New ideas about atrial fibrillation 50 years on. Nature 415, 219-226 (2002).
2. Thompson, P. D. et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 107, 3109-3116 (2003).
3. Grimsmo, J., Grundvold, I., Maehlum, S. & Arnesen, H. High prevalence of atrial fibrillation in long-term endurance cross-country skiers: echocardiographic findings and possible predictors-a 28-30 years follow-up study. Eur. J. Cardiovasc. Prev. Rehabilit. 17, 100-105 (2010).
4. Mont, L., Elosua, R. & Brugada, J. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace 11, 11-17 (2009).
5. Myrstad, M. et al. Increased risk of atrial fibrillation among elderly Norwegian men with a history of long-term endurance sport practice. Scand. J. Med. Sci. Sports 24, e238-e244 (2014).
6. Andersen, K. et al. Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur. Heart J. 34, 3624-3631 (2013).
7. Guasch, E. et al. Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model. J. Am. Coll. Cardiol. 62, 68-77 (2013).
8. Schotten, U., Neuberger, H. R. & Allessie, M. A. The role of atrial dilatation in the domestication of atrial fibrillation. Prog. Biophys. Mol. Biol. 82, 151-162 (2003).
9. Li, D., Fareh, S., Leung, T. K. & Nattel, S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100, 87-95 (1999).
10. Engelmann, M. D. & Svendsen, J. H. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur. Heart J. 26, 2083-2092 (2005).
11. Dixon, E. M., Kamath, M. V., McCartney, N. & Fallen, E. L. Neural regulation of heart rate variability in endurance athletes and sedentary controls. Cardiovasc. Res. 26, 713-719 (1992).
12. Pelliccia, A. et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J. Am. Coll. Cardiol. 46, 690-696 (2005).
13. Weight, L. M., Alexander, D. & Jacobs, P. Strenuous exercise: analogous to the acute-phase response? Clin. Sci. 81, 677-683 (1991).
14. Bernecker, C. et al. Evidence for an exercise induced increase of TNF-alpha and IL-6 in marathon runners. Scand. J. Med. Sci. Sports 23, 207-214 (2013).
15. Reeves, J. T. et al. Operation Everest II: Cardiac filling pressures during cycle exercise at sea level. Respir. Physiol. 80, 147-154 (1990).
16. Matthews, N. Tumour-necrosis factor from the rabbit. II. Production by monocytes. Br. J. Cancer 38, 310-315 (1978).
17. Sun, M. et al. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 115, 1398-1407 (2007).
18. Kapadia, S. R. et al. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ. Res. 81, 187-195 (1997).
19. Saba, S. et al. Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-{alpha}. Am. J. Physiol.-Heart Circ. Physiol. 289, H1456 (2005).
20. Esteve-Lanao, J., Foster, C., Seiler, S. & Lucia, A. Impact of training intensity distribution on performance in endurance athletes. J. Strength Cond. Res. 21, 943-949 (2007).
21. Pluim, B. M., Zwinderman, A. H., van der Laarse, A. & van der Wall, E. E. The athlete's heart. A meta-analysis of cardiac structure and function. Circulation 101, 336-344 (2000).
22. Everett, T. H. et al. Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling. Am. J. Physiol.-Heart Circ. Physiol. 291, H2911-H2923 (2006).
23. Schotten, U., Verheule, S., Kirchhof, P. & Goette, A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol. Rev. 91, 265-325 (2011).
24. Alessi, R., Nusynowitz, M., Abildskov, J. A. & Moe, G. K. Nonuniform distribution of vagal effects on the atrial refractory period. Am. J. Physiol. 194, 406-410 (1958).
25. Kovoor, P. et al. Evaluation of the role of I(KACh) in atrial fibrillation using a mouse knockout model. J. Am. Coll. Cardiol. 37, 2136-2143 (2001).
26. Voigt, N. et al. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation 129, 145-156 (2014).
27. Neef, S. et al. CaMKII-dependent diastolic SR Ca2 + leak and elevated diastolic Ca2 + levels in right atrial myocardium of patients with atrial fibrillation. Circ. Res. 106, 1134-1144 (2010).
28. Li, N. et al. Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice. Circ. Res. 110, 465-470 (2012).
29. Respress, J. L. et al. Role of RyR2 phosphorylation at S2814 during heart failure progression. Circ. Res. 110, 1474-1483 (2012).
30. Erickson, J. R. et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133, 462-474 (2008).
31. Powers, S. K. & Jackson, M. J. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol. Rev. 88, 1243-1276 (2008).
32. Spach, M. S. Mounting evidence that fibrosis generates a major mechanism for atrial fibrillation. Circ. Res. 101, 743-745 (2007).
33. Aviles, R. J. et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108, 3006-3010 (2003).
34. Rosas, M., Thomas, B., Stacey, M., Gordon, S. & Taylor, P. R. The myeloid 7/4-antigen defines recently generated inflammatory macrophages and is synonymous with Ly-6B. J. Leukoc. Biol. 88, 169-180 (2010).
35. van Deel, E. D. et al. Exercise training does not improve cardiac function in compensated or decompensated left ventricular hypertrophy induced by aortic stenosis. J. Mol. Cell. Cardiol. 50, 1017-1025 (2011).
36. Oeckinghaus, A. & Ghosh, S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harbor perspect. Biol. 1, a000034 (2009).
37. Zarubin, T. & Han, J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15, 11-18 (2005).
38. Palomer, X. et al. TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. Cardiovasc. Res. 81, 703-712 (2009).
39. Li, J. et al. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm 7, 438-444 (2010).
40. Li, M. et al. p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart. Circulation 111, 2494-2502 (2005).
41. Horiuchi, T., Mitoma, H., Harashima, S., Tsukamoto, H. & Shimoda, T. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology 49, 1215-1228 (2010).
42. Venkatesh, D. et al. Endothelial TNF receptor 2 induces IRF1 transcription factor-dependent interferon-beta autocrine signaling to promote monocyte recruitment. Immunity 38, 1025-1037 (2013).
43. Hohensinner, P. J. et al. Macrophage colony stimulating factor expression in human cardiac cells is upregulated by tumor necrosis factor-alpha via an NF-kappaB dependent mechanism. J. Thrombosis Haemostasis 5, 2520-2528 (2007).
44. Porter, K. E., Turner, N. A., O'Regan, D. J. & Ball, S. G. Tumor necrosis factor induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. Cardiovasc. Res. 64, 507 (2004).
45. Kumar, A. & Boriek, A. M. Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy. FASEB J. 17, 386-396 (2003).
46. Yokoyama, T. et al. Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts. Am. J. Physiol. 276, H1968-H1976 (1999).
47. Zhu, J. H. et al. Cyclic stretch stimulates vascular smooth muscle cell alignment by redox-dependent activation of Notch3. Am. J. Physiol. Heart. Circ. Physiol. 300, H1770-H1780 (2011).
48. Hamilton, D. R. et al. Right atrial and right ventricular transmural pressures in dogs and humans. Effects of the pericardium. Circulation 90, 2492-2500 (1994).
49. Ohba, H. et al. Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men. Am. Heart. J. 141, 751-758 (2001).
50. Burstein, B., Libby, E., Calderone, A. & Nattel, S. Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation 117, 1630-1641 (2008).
51. Kleinbongard, P., Schulz, R. & Heusch, G. TNFalpha in myocardial ischemia/reperfusion, remodeling and heart failure. Heart Fail. Rev. 16, 49-69 (2011).
52. Mann, D. L. et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109, 1594-1602 (2004).
53. Jobe, L. J. et al. TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload. Am. J. Physiol. Heart. Circ. Physiol. 297, H1462-H1468 (2009).
54. Rose, S. et al. A novel mouse model that develops spontaneous arthritis and is predisposed towards atherosclerosis. Ann. Rheum. Dis. 72, 89-95 (2013).
55. Kyoi, S. et al. Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster. Cardiovasc. Res. 69, 888-898 (2006).
56. Hoogsteen, J., Schep, G., Van Hemel, N. M. & Van Der Wall, E. E. Paroxysmal atrial fibrillation in male endurance athletes. A 9-year follow up. Europace 6, 222-228 (2004).
57. Yang, K. C., Tseng, Y. T. & Nerbonne, J. M. Exercise training and PI3Kalpha-induced electrical remodeling is independent of cellular hypertrophy and Akt signaling. J. Mol. Cell Cardiol. 53, 532-541 (2012).
58. Defer, N., Azroyan, A., Pecker, F. & Pavoine, C. TNFR1 and TNFR2 signaling interplay in cardiac myocytes. J. Biol. Chem. 282, 35564-35573 (2007).
59. Couchonnal, L. F. & Anderson, M. E. The role of calmodulin kinase II in myocardial physiology and disease. Physiology 23, 151-159 (2008).
60. Kreusser, M. M. et al. Cardiac CaM Kinase II Genes delta and gamma contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy. Circulation 130, 1262-1273 (2014).
61. Pelliccia, A. et al. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation 105, 944-949 (2002).
62. Heeringa, J. et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur. Heart J. 27, 949-953 (2006).
63. Mont, L. et al. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace 10, 15-20 (2008).
64. Bruunsgaard, H., Pedersen, M. & Pedersen, B. K. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 8, 131-136 (2001).
65. Bartolomucci, A. et al. Chronic psychosocial stress persistently alters autonomic function and physical activity in mice. Physiol. Behav. 80, 57-67 (2003).
66. Skoluda, N., Dettenborn, L., Stalder, T. & Kirschbaum, C. Elevated hair cortisol concentrations in endurance athletes. Psychoneuroendocrinology 37, 611-617 (2012).
67. Rose, R. A. et al. Iron overload decreases CaV1.3-dependent L-type Ca2 + currents leading to bradycardia, altered electrical conduction, and atrial fibrillation. Circ. Arrhythmia Electrophysiol. 4, 733-742 (2011).
68. Mironov, S., Jalife, J. & Tolkacheva, E. G. Role of conduction velocity restitution and short-term memory in the development of action potential duration alternans in isolated rabbit hearts. Circulation 118, 17-25 (2008).
69. Hadi, A. M. et al. Rapid quantification of myocardial fibrosis: a new macro-based automated analysis. Cell Oncol. (Dordr) 34, 343-354 (2011).
70. Picht, E., Zima, A. V., Blatter, L. A. & Bers, D. M. SparkMaster: automated calcium spark analysis with ImageJ. Am. J. Physiol. Cell Physiol. 293, C1073-C1081 (2007).